SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Vincent van Gogh — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientVincent van Gogh
Date of birth1853-03-30
IdentifiersMRN HR-NI010-SYN-TD; SSN (made up) 000-10-3198
Document date1889-04-20
AuthorElise Verhoeven, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Three-month review with the 12-week metabolic check. [S]

History of Present Illness

Mr. van Gogh returns three months after his first visit, fifteen weeks after aripiprazole was started in hospital, fasting for his blood tests. He has had no voices, suspiciousness, or confusion since the six-week visit. He takes aripiprazole 10 mg and naltrexone every morning. He sleeps about seven hours and goes to bed by midnight; he noticed once that after a late night of work he felt a rush of ideas the next day, and he went to bed early as his plan says. He paints most days, outdoors now that spring has come, and has sold two paintings. He drinks one glass of wine with dinner on most days and none on two days a week. His appetite is a little greater than before. His mood is steady; he has not had thoughts of suicide or self-harm. [S]

ElementDetail
Psychotic symptomsNone since the six-week visit
Early warning signsOne day of racing ideas after a late night; managed with sleep
SleepAbout seven hours at regular times
AlcoholOne glass of wine with dinner on most days; two alcohol-free days a week
MoodSteady; PHQ-9 6; item 9 scored 0
WeightAppetite slightly greater; weight up 1.7 kg since intake

Review of Systems

SystemResultFinding
ConstitutionalPositiveAppetite a little greater; weight up 1.7 kg
EndocrineNegativeNo thirst or frequent urination
NeurologicalNegativeNo restlessness, stiffness, tremor, or seizures
PsychiatricNegativeNo voices or suspiciousness; mood steady; no thoughts of suicide or self-harm

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aripiprazole 10 mg oral tablet, one tablet by mouth once daily (started in hospital)One tablet by mouth once dailyOral route1889-01-05 to 1889-02-02completedS
Aripiprazole 15 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once dailyOral route1889-02-02 to 1889-02-16completedS
Naltrexone 50 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once dailyOral route1889-02-02activeS
Thiamine 100 mg oral tablet, one tablet by mouth daily (started in hospital)One tablet by mouth dailyOral route1889-01-05 to 1889-07-20completedS
Aripiprazole 10 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once dailyOral route1889-02-16activeS
Propranolol 10 mg oral tablet, one tablet by mouth twice daily for akathisiaOne tablet by mouth twice dailyOral route1889-02-16 to 1889-03-02completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1889-04-20Body height170cmS
1889-04-20Body weight65.7kgS
1889-04-20Body mass index (BMI) [Ratio]22.7kg/m2S
1889-04-20Systolic blood pressure122mm[Hg]S
1889-04-20Diastolic blood pressure78mm[Hg]S
1889-04-20Heart rate74/minS
1889-04-20Respiratory rate14/minS
1889-04-20Body temperature36.7CelS
1889-04-20Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1889-04-20Fasting glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
1889-04-20Hemoglobin A1c/Hemoglobin.total in Blood5.4%Below 5.7% is normal; 5.7 to 6.4% prediabetesNormalS
1889-04-20Cholesterol [Mass/volume] in Serum or Plasma191mg/dL<=199 mg/dLNormalS
1889-04-20Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation112mg/dL<=129 mg/dLNormalS
1889-04-20Cholesterol in HDL [Mass/volume] in Serum or Plasma50mg/dL>=40 mg/dLNormalS
1889-04-20Triglyceride [Mass/volume] in Serum or Plasma142mg/dL<=149 mg/dLNormalS
1889-04-20Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma33U/L10-40 U/LNormalS
1889-04-20Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma31U/L7-56 U/LNormalS
1889-04-20Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma49U/L8-61 U/LNormalS
1889-04-20Phosphatidylethanol [Mass/volume] in Blood46ng/mLBelow 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinkingHighS
1889-04-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S

Physical Exam

Vital signs recorded on 1889-04-20; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 65.7 kg, BMI 22.7; waist 87 cm; blood pressure 122/78, pulse 74
NeurologicalNo akathisia, rigidity, tremor, or abnormal movements
PsychiatricEuthymic; organized; no psychotic features; speech normal in rate

Problems

ProblemClinical statusVerificationCodeProvenance
First episode of psychosis with mood features: weeks of very little sleep, intense work and expansive plans, then acute confusion, hallucinations and suspiciousness with self-injury, and low mood since discharge. Diagnosis provisional; differential: bipolar I disorder with psychotic features, brief psychotic or schizophreniform disorder, alcohol withdrawal delirium or alcohol-induced psychotic disorder, and psychosis related to focal epilepsy. Synthetic modern episode linked to his documented first crisisactiveprovisional F29S — Synthetic modern coding of the documented first crisis. Unspecified psychosis is coded because the cause is not yet established; the retrospective diagnoses stay in the claims.
Alcohol use disorder, moderate (heavy daily wine and anise spirits before the episode); synthetic modern episode linked to his documented heavy drinkingactiveconfirmed F10.20S — Synthetic modern coding of the documented drinking and its retrospective interpretation.
Self-injury to the left ear during the acute confusional episode, without suicidal intent; wound healed after surgical care in hospitalactiveconfirmed Z91.52S — Synthetic modern coding of the documented injury; no detail of the injury is recorded.
Akathisia from aripiprazole, two weeks after the dose was increased to 15 mg; treated by returning to 10 mg and short-term propranolol; resolvedresolvedconfirmed G25.71S — Synthetic medication side effect; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
Medication safetyAntipsychotic dose, adherence, and responseEvery visitCompleted todayAripiprazole 10 mg; full adherence; in remission
SurveyPsychotic and mood symptoms, and early warning signsEvery visitCompleted todayNo psychotic symptoms; one day of racing ideas after a late night, managed with sleep
ExaminationAkathisia, parkinsonism, and sedationEvery visit in the first months and after any dose changeCompleted todayNone
ExaminationWeight and BMIEvery visit for 6 months after starting, then quarterly (CMID: baseline, 4, 8, and 12 weeks, then quarterly)Completed today65.7 kg (BMI 22.7), up 2.7% from intake. Taken at 15 weeks rather than the CMID's 12, within the APA's four months
ExaminationWaist circumferenceBaseline, then yearlyCompleted today87 cm
ExaminationBlood pressureBaseline, 12 weeks, then yearlyCompleted today122/78
LaboratoryFasting glucose and A1cBaseline, 12 weeks to 4 months, then yearlyCompleted todayFasting glucose 94 mg/dL; A1c 5.4%; yearly from now
LaboratoryFasting lipid panelBaseline, 12 weeks to 4 months, then yearlyCompleted todayTotal cholesterol 191, LDL 112, HDL 50, triglycerides 142 mg/dL; yearly from now
SurveyDepression measure (PHQ-9)Monthly during acute treatment, every 2 to 4 weeks in continuation, then periodicallyDeferredPHQ-9 6 today, item 9 scored 0. No PHQ-9 was taken in the seven weeks since the six-week visit, longer than the monthly measure advised during acute treatment, because no visit fell in that time. No harm resulted: the score fell from 8 to 6 and the care coordinator saw him weekly. Corrective action: the care coordinator now gives the PHQ-9 monthly between visits
SurveySuicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; safety plan reviewed; no firearm access
Self-managementSleepEvery visitCompleted todayAbout seven hours; in bed by midnight
SurveyDrinking (AUDIT-C and PEth)PEth at intake and at each check while drinking continues; AUDIT-C yearlyCompleted todayPEth 46 ng/mL
Medication safetyNaltrexone: liver tests and opioid exposureLiver tests before starting, then at 1 to 3 months and every 6 to 12 monthsCompleted todayAST 33, ALT 31, GGT 49 U/L, normal
Medication safetyThiamineWhile drinking heavilyCompleted todayTaking thiamine daily
Self-managementCoordinated specialty care engagementOngoing, for up to two to three yearsCompleted todayTherapist every two weeks; peer specialist monthly; supported work plan: selling his paintings again

Goal progress:

Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018); Consensus development conference on antipsychotic drugs and obesity and diabetes (2004); Recovery After an Initial Schizophrenia Episode (RAISE): coordinated specialty care for first-episode psychosis (2026); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: Preventive visit in eight weeks. Six-month review with the AIMS, PEth, liver tests, and blood count. Care coordinator monthly, with the PHQ-9. Next scheduled visit 1889-06-15: periodic adult preventive visit. [S]